Is Coffee Bad for Prostate Cancer?

Coffee does not appear to be bad for prostate cancer. In fact, the bulk of the evidence points in the opposite direction: men who drink coffee regularly tend to have a modestly lower risk of developing prostate cancer, and the protective association grows stronger when researchers look specifically at aggressive and fatal forms of the disease. A large 2021 meta-analysis of 16 prospective studies found that the highest coffee consumers had about a 9% lower risk of prostate cancer compared to the lowest consumers, with each additional daily cup associated with roughly a 1% further reduction in risk.¹ That said, the relationship is more complicated than “coffee prevents prostate cancer,” and a few important caveats shape what the numbers mean for any individual.

What the Big Studies Actually Show

The research on coffee and prostate cancer comes almost entirely from observational studies, meaning researchers tracked large groups of men over years and compared cancer rates between different levels of coffee consumption. No one has run a randomized trial assigning men to drink coffee or skip it, and that matters because observational data can show associations but cannot prove one thing caused another. Still, the consistency of the findings across many populations is what makes the case interesting.

An earlier meta-analysis of prospective cohort studies, published in 2014, found that regular coffee drinkers had about a 12% lower risk of prostate cancer compared to men who rarely or never drank coffee.² A Japanese cohort study followed over 18,000 men and found that those drinking three or more cups a day had roughly 37% lower risk compared to non-drinkers, with a clear dose-response trend.³ And one of the most influential individual studies, based on nearly 48,000 men in the U.S. Health Professionals Follow-up Study, reported that men drinking six or more cups daily had about an 18% lower risk of overall prostate cancer and a striking 60% lower risk of lethal prostate cancer compared with non-drinkers.⁴

Not every study agrees, though. A large analysis from the European Prospective Investigation into Cancer and Nutrition found no association between coffee or tea consumption and prostate cancer risk of any stage, grade, or fatality level.⁵ That null finding is worth taking seriously because the study was large and well-designed. The overall picture, when you step back from any single study, leans toward a modest protective association, but with enough inconsistency to keep researchers cautious about strong claims.

The Effect on Aggressive Versus Low-Grade Disease

One of the more intriguing patterns in the data is that coffee’s apparent benefit is not spread evenly across all types of prostate cancer. The association is weaker, sometimes even absent, for slow-growing, localized tumors. It is strongest for the kinds of prostate cancer that actually kill men: high-grade, advanced, and fatal disease.

A dose-response meta-analysis from 2014 quantified this pattern. For every three additional cups of coffee per day, the pooled risk of fatal prostate cancer dropped by about 11%, while the risk of low-grade prostate cancer barely budged.⁶ A Swedish case-control study found that the highest coffee intake was associated with half the risk of the most aggressive tumors, those with Gleason scores of 8 to 10.⁷ This selective association with aggressive disease is what has made researchers pay attention: it suggests coffee might influence pathways that matter most for cancer progression rather than just the initial development of any prostate tumor.

A Swedish population-based study found a smaller and non-significant association for advanced and fatal prostate cancer individually, with about a 2% reduction per additional cup.⁸ The mixed size of the effect across populations is a reminder that the protective signal, while present, is not overwhelming.

What in Coffee Might Be Responsible

Coffee is one of the most chemically complex beverages people consume, containing hundreds of bioactive compounds. Researchers have zeroed in on a few that show anticancer activity in laboratory settings. Two coffee-specific oils called kahweol acetate and cafestol have drawn particular interest. In cell-culture experiments, these diterpenes slowed the growth and migration of prostate cancer cells in a dose-dependent way, triggered programmed cell death, and reduced androgen receptor activity in hormone-sensitive cancer cells.⁹ Follow-up laboratory work found that the same compounds also inhibited prostate cancer cell lines that had become resistant to standard chemotherapy drugs.¹⁰

Beyond those diterpenes, coffee is rich in chlorogenic acid and other polyphenols with antioxidant and anti-inflammatory properties. A study testing extracts from green and roasted coffee beans on metastatic prostate cancer cell lines found that green and lightly roasted coffees had the highest antioxidant activity and were most effective at stopping cancer cell growth and triggering cell death, while dark roast extracts had less effect.¹¹ This suggests the roasting process degrades some of the compounds responsible for the anticancer activity seen in the lab.

A review of the molecular mechanisms linked coffee consumption to several pathways relevant to prostate cancer, including reduced inflammation, improved insulin sensitivity, and altered hormone levels. Coffee has been associated with lower estrogen, lower prostate-specific antigen, and modulated glucose metabolism, all of which could theoretically influence prostate cancer development.¹² The challenge is translating these laboratory and mechanistic observations into confidence about what happens inside actual human prostate tissue. A study within the Health Professionals Follow-up Study tried to connect coffee consumption to specific molecular markers in prostate tumors, looking at a signaling pathway often disrupted in aggressive cancer. It found only tiny, statistically insignificant differences between heavy coffee drinkers and non-drinkers in the molecular markers examined.¹³ So the human tissue evidence has not yet caught up with the promise of the cell-culture studies.

Does Coffee Help After a Prostate Cancer Diagnosis?

A separate question from prevention is whether coffee influences outcomes for men already diagnosed with prostate cancer. A few studies have tackled this. Among men with non-metastatic prostate cancer, drinking four or more cups of coffee daily was associated with a roughly 59% lower risk of cancer recurrence or progression compared to drinking one cup a week or less.¹⁴ That same study found no statistically significant link between daily coffee drinking and prostate cancer-specific death, so the picture is nuanced even in the post-diagnosis setting.

Smoking appears to complicate the relationship substantially. A study tracking prostate cancer progression found that among men who had never smoked, higher coffee intake was not significantly associated with progression risk. But among current smokers at the time of diagnosis, drinking five cups of coffee a day was associated with more than four times the risk of disease progression compared to non-drinkers. The interaction between smoking and coffee was strong enough to reach statistical significance. Among former and never smokers, decaffeinated coffee showed a modest inverse association with progression risk.¹⁵ This finding is based on a relatively small number of events, so it should be interpreted carefully, but it raises a legitimate flag for men who smoke and drink a lot of coffee.

Your Genetics May Change the Story

People metabolize caffeine at very different speeds, and this variation is largely genetic. The enzyme responsible for breaking down caffeine in the liver is encoded by a gene called CYP1A2, and common variants of this gene make some people “fast metabolizers” and others “slow metabolizers.” A study of men with prostate cancer found that high coffee intake was associated with better prostate cancer-specific survival among men who carried the fast-metabolizer genotype, but not among slow metabolizers.¹⁶ This is a single study, and it does not mean slow metabolizers are harmed by coffee, but it adds a layer of biological plausibility to the idea that the effects of coffee are not identical for everyone.

Most people do not know their CYP1A2 genotype, and genetic testing for coffee metabolism is not part of standard clinical care. But the finding helps explain why studies of different populations sometimes produce different results: the genetic makeup of the group being studied can shift the average effect.

Brewing Method and Roast Level Matter

If the anticancer compounds in coffee include diterpenes like kahweol acetate and cafestol, then how you brew your coffee changes what you actually consume. These oils are trapped by paper filters but pass freely through metal mesh. A recent comparison of brewing methods found that workplace bean-to-cup machines produced median cafestol levels around 176 mg/L, while standard home-brewed paper-filtered coffee contained only about 12 mg/L. Boiled coffee, the kind traditional in Scandinavian and Turkish preparation, had the highest concentrations of all at 939 mg/L of cafestol. French press coffee fell in between, at roughly 90 mg/L.¹⁷

This creates an awkward tradeoff. The same diterpenes that show anticancer activity in the lab are also known to raise LDL cholesterol when consumed in large amounts. Paper-filtered coffee strips them out, which is better for your cholesterol but may also remove some of the cancer-relevant compounds. The epidemiological studies largely did not distinguish between brewing methods, so we do not know whether the protective association with prostate cancer holds equally for all preparations. If the diterpenes are driving part of the benefit, unfiltered methods like French press or espresso might deliver more of the relevant compounds, but with cardiovascular trade-offs that need weighing.

Roasting also reshapes the chemical profile. As noted earlier, lighter roasts retain higher levels of chlorogenic acid and show greater anticancer activity in lab settings than dark roasts.¹¹ Dark roasting degrades many of the polyphenol compounds responsible for antioxidant effects. Whether this translates into meaningful differences in actual cancer risk for coffee drinkers is unknown, but it is a reasonable factor to consider if you are choosing between roasts for health reasons.

Coffee and PSA Screening

Prostate-specific antigen (PSA) testing is the most common screening tool for prostate cancer, and some men wonder whether coffee intake could skew their results. A study examining dietary caffeine and PSA levels found that men with elevated PSA actually had lower caffeine intake on average. However, after adjusting for other factors, neither dietary caffeine intake nor urinary caffeine metabolite levels were significantly associated with elevated PSA.¹⁸ In practical terms, your morning coffee is unlikely to meaningfully alter a PSA test result, so there is no reason to skip it before a screening blood draw on that basis alone.

Coffee, Caffeine, and Urinary Symptoms

Men with prostate concerns often deal with lower urinary tract symptoms: frequent urination, urgency, weak stream, and nighttime bathroom trips. These symptoms are usually caused by benign prostatic enlargement rather than cancer, but they overlap in the population of men being screened and treated for prostate issues. Caffeine is a bladder stimulant and mild diuretic, so it can worsen urgency and frequency in some men regardless of what is happening with their prostate.

A systematic review of the evidence on diet and lower urinary tract symptoms found that the relationship between caffeine intake and benign prostate enlargement is unclear. The few studies that examined it had conflicting results, and the evidence was limited primarily to coffee intake rather than caffeine from all sources. One large cross-sectional study found that higher coffee consumption was actually associated with more benign prostate enlargement, while two older studies found no significant link. The overall evidence was judged too thin to draw firm conclusions.

For men who already experience bothersome urinary symptoms, the practical issue with coffee is not cancer risk but symptom management. Reducing caffeine can sometimes ease urgency and frequency, and urologists commonly suggest this as a first-line behavioral change. This is distinct from the cancer question, but it is the coffee-and-prostate issue that most men encounter in daily life.

Racial and Ethnic Differences in the Evidence

Most of the large studies on coffee and prostate cancer were conducted in predominantly White or East Asian populations. Given that prostate cancer incidence and mortality rates vary dramatically across racial and ethnic groups, with Black men facing the highest burden in the United States, it matters whether the association holds across different populations.

Data from the Southern Community Cohort Study, which enrolled a large proportion of Black participants, looked at coffee consumption and cancer risk among African Americans. For prostate cancer specifically, no statistically significant association was found, though the trend was in the direction of lower risk with higher coffee intake, consistent with the broader literature. The study’s estimates for prostate cancer were below 1.0, meaning they pointed toward a possible protective effect, but the confidence intervals were wide enough that chance could not be ruled out.¹⁹ The finding is not alarming, but it does highlight that we cannot confidently extend the protective association seen in other populations to Black men without more data.

What About Caffeine Specifically Versus Whole Coffee

Many of the compounds implicated in coffee’s potential anticancer effects are not caffeine. The diterpenes, the chlorogenic acids, and other polyphenols are present regardless of whether the coffee is caffeinated or decaffeinated. Some studies have tried to separate the effects. The Health Professionals Follow-up Study found that the protective association held for both regular and decaf coffee, suggesting caffeine alone was not the main driver.⁴ In the post-diagnosis study that found a worrisome interaction with smoking, decaf coffee was actually the type associated with reduced progression risk among non-smokers and former smokers.¹⁵

This is useful information for men who are sensitive to caffeine’s side effects, including anxiety, insomnia, or palpitations, or who need to limit caffeine for cardiovascular reasons. Switching to decaf does not seem to strip away whatever is in coffee that might benefit the prostate. It may even be the smarter choice for men who want the potential upside without the stimulant effects, particularly if they are dealing with sleep disruption from treatment or aging.

An Animal Study Worth Mentioning

One rat study added a wrinkle to the story by finding that chronic caffeine intake increased androgen receptor expression and epithelial cell proliferation in the prostate, essentially stimulating prostate tissue growth.²⁰ This finding runs counter to the human epidemiological data showing a protective association and illustrates why translating animal research to human health is tricky. Rat prostate biology differs from human prostate biology in important ways, and the doses used in animal studies often do not correspond to realistic human consumption. The human data, drawn from hundreds of thousands of men followed for years, carries far more weight for answering the practical question of whether coffee is safe for your prostate.

Still, the rat study is a reminder that “coffee” and “caffeine” are not interchangeable. Coffee’s apparent benefit may come from the non-caffeine compounds working together, while isolated caffeine at high doses could have its own distinct effects on prostate tissue. This distinction matters as the field moves toward understanding which specific molecules deserve further study and possibly clinical testing.